In a new study led by the Lawson Health Research Institute, researchers challenged the idea that cancer that spreads from an original tumour to other parts of the body is incurable.

The founder of London's First Episode Mood and Anxiety Program, or FEMAP, is hoping the results of a new study help inform future health care delivery models.

$4.4 million in funding over five years will expand a London program that uses DNA analysis to predict how patients will respond to medication.